13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001398344-25-002783
Total Value
$3.6M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $1.9M | 53.75% |
| 2 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $871,871 | 24.47% |
| 3 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $775,782 | 21.77% |